Recent studies have demonstrated that TDO2 is expressed in diverse tumor types, including hepatocellular carcinoma, non-small cell lung cancer, ovarian carcinoma, and renal cell carcinoma [26, 27]. Here, TDO2 is linked to ovarian carcinoma.